Serina Therapeutics, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Serina Therapeutics, Inc. (SER) had Deferred Tax Assets, Operating Loss Carryforwards of $29.80 million as of 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-25
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $29.80M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $22.46M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $10.17M; Deferred Tax Assets, Operating Loss Carryforwards as first filed $14.28M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $12.41M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $29.80M 10-K · filed 2026-03-25 | |
| 2024-12-31 | $22.46M 10-K · filed 2026-03-25 | |
| 2023-12-31 | $10.17M 10-K · filed 2025-03-24 | $14.28M 10-K · filed 2024-03-22 |
| 2022-12-31 | $12.41M 10-K · filed 2024-03-22 | |
| 2021-12-31 | $12.00M 10-K · filed 2023-03-31 | |
| 2020-12-31 | $13.96M 10-K · filed 2022-03-29 | |
| 2019-12-31 | $12.40M 10-K · filed 2021-03-31 | |
| 2018-12-31 | $9.89M 10-K/A · filed 2020-03-31 | |
| 2017-12-31 | $8.37M 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |